NCT03994588

Brief Summary

Complex ventral hernia is a challenging problem well known to be associated with occurrence of serious complications. The major problems encountered in such cases Include: loss of domain with subsequent increase of intra-abdominal pressure after repair, the huge musculo-fascial defect and skin scarring with possible skin viability problem resulting from the dissection of skin flaps. There is no unified accepted evidence-based approach for its repair and is attended with a high recurrence rate that may reach up to 67%. In a previous study using the ADMIR technique of intraperitoneal repair and after a long-term follow-up the investigator was able to reduce the recurrence rate to 4% after an average follow up period of 142 months. In the current study the investigator will use the same technique of intraperitoneal mesh repair comparing the polypropylene light weight, wide pore, soft mesh with a double mesh using the same polypropylene mesh and a vicryl mesh as a protective layer against the bowel. If it is proven as effective as the mesh with protective layer and with no increased risk of morbidity, this will result in marked reduction of the cost of treatment by nearly 90 % and will abolish the waiting list of patients as the polypropylene mesh is readily available.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 21, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

July 12, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

4.1 years

First QC Date

June 20, 2019

Last Update Submit

February 14, 2024

Conditions

Keywords

Complex ventral herniaPolypropylene soft meshIntraperitoneal repairRecurrenceLoss of Domain

Outcome Measures

Primary Outcomes (1)

  • The development of persistent abdominal pain (VAS), intestinal obstruction or abdominal wall sinus or fistula formation.

    Manifestations of intestinal obstruction in the form of abdominal pain (VAS), abdominal distention, vomiting and absolute constipation

    one year

Secondary Outcomes (1)

  • Hernia recurrence.

    three years

Study Arms (2)

study arm

ACTIVE COMPARATOR

In this arm a light weight, wide pore, soft polypropylene mesh will be used for intraperitoneal hernia repair

Procedure: Intraperitoneal Mesh hernia repair

control

ACTIVE COMPARATOR

in this arm a double mesh (vicryl + polypropylene mesh) will be used for intraperitoneal hernia repair.

Procedure: Intraperitoneal Mesh hernia repair

Interventions

The mesh will be inserted intraperitoneally for complex ventral hernia repair and fixed according the previously described ADMIR technique.

controlstudy arm

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients between 18 and 65 years of age, ASA physical status I - III with complex ventral hernia (defect width above 10 cm, loss of domain above 20 %, recurrent hernia and/or associated with fistula or abdominal wall sinuses).

You may not qualify if:

  • Age below 18 and above 65 years. The maximum age limit would be 65 years because in our previous studies morbidity was higher in older age group (36, 37).
  • Body mass index greater than 45 kg/m2 or weight above 100 kg.
  • Pregnancy.
  • Associated non treated abdominal malignancy.
  • Unstable coronary artery disease, congestive heart failure.
  • Significant renal or hepatic impairment;
  • Severe bronchopulmonary disease, including chronic obstructive pulmonary disease and obstructive sleep apnea.
  • Diabetics with Hb A1c above 7.5.
  • Subjects with loss of domain above 20 % who didn't respond to pre-operative progressive pneumoperitoneum.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University Hospitals

Cairo, Egypt

Location

MeSH Terms

Conditions

Hernia, VentralRecurrence

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Officials

  • Raafat Y Afifi, MD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient will be blinded to the study group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of General Surgery - primary investigator

Study Record Dates

First Submitted

June 20, 2019

First Posted

June 21, 2019

Study Start

July 12, 2019

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

Data can be shared at the end of the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
one year
Access Criteria
email contact

Locations